Robert Nelsen insider trades
Open-market stock purchases and sales by Robert Nelsen, Director, 10% Owner at City Therapeutics, Inc, from SEC Form 4 filings since Jun 2, 2010.
Track record: 22% of 9 scored buys are up 5% or more since purchase, averaging -46%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought | $3.1M |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 15, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Jun 5, 2026 | PRME Prime Medicine, Inc | Bought (not open market) | — |
| Jun 4, 2026 | SANA Sana Biotechnology, Inc | Bought (not open market) | — |
Companies traded
- CTY City Therapeutics, Inc: 1 buy, last Oct 19, 2026
- PRME Prime Medicine, Inc: 3 buys, last Jun 5, 2026
- SANA Sana Biotechnology, Inc: 2 buys, last Jun 4, 2026
- LYEL Lyell Immunopharma, Inc: other filings, last Jun 14, 2024
- VIR Vir Biotechnology, Inc: 1 buy, last May 30, 2024
- DNLI Denali Therapeutics Inc: other filings, last Jun 2, 2021
- KRTX Karuna Therapeutics, Inc: 1 buy, last Apr 13, 2021
- BEAM Beam Therapeutics Inc: other filings, last Mar 31, 2021
- UBX Unity Biotechnology, Inc: other filings, last Jun 18, 2020
- DNI Denali Therapeutics Inc: other filings, last Aug 8, 2019
- SNNA Sienna Biopharmaceuticals, Inc: other filings, last Jun 1, 2018
- JUNO Juno Therapeutics, Inc: other filings, last Mar 5, 2018